NCRAD: A national biobank for Alzheimer’s disease samples

The biobank curates an extensive repository of biospecimens, providing researchers with a rich pool of data to advance studies and make groundbreaking discoveries in Alzheimer's disease and related dementias investigators. To ensure that researchers have access to the most accurate information, NCRAD continually updates its database with new information. They take pride in their rigorous procedures and researcher-friendly approach to sample banking. From new studies to closed studies, the biobank assists researchers every step of the way.

NCRAD has expanded its services with the establishment of the Biomarker Assay Laboratory. This state-of-the-art facility is equipped with the latest technology and staffed by experienced personnel with extensive knowledge in the field of biomarker analysis. The lab analyzes well-established fluid-based biomarkers to support research studies in Alzheimer's disease, allowing for longitudinal quality monitoring and consistent delivery of results over time. The lab's approach enables cross-laboratory comparability studies to be conducted to ensure standardized processing and reliable research biomarker results.